[This review was originally posted at the Nieman Journalism Lab Zoloft For Sale, on May 11, 2012.]

Slideshows, Facebook apps, and annoyed readers: After a few weeks revolving around News Corp., the media-watching world seemed to fixate on The Washington Post this week, focusing specifically on two developments: First, Adweek’s Lucia Moses reported that several top Post editors and reporters met with the newspaper’s president, Steve Hills, and that among other things, he urged them to produce more pageview-grabbing slideshows.

The Atlantic Wire’s Alexander Abad-Santos called it “one of the more disturbing things you’ll hear from someone in charge of one America’s best papers,” and his colleague, Alexis Madrigal, further explained the futility of slideshows. Those slideshows, he argued, Zoloft pics, may be producing more pageviews, but they’re not actually drawing more people. And the people that do read them come away with the feeling that the site doesn’t value them. “People know when your product is cheap; there is no ‘trick’ of the web,” he wrote.

The second development came when Forbes’ Jeff Bercovici reported that the number of users of its Facebook Social Reader had dropped precipitously over the past month or so, Zoloft For Sale. Zoloft photos, BuzzFeed’s John Herrman noticed that a lot of other Facebook social apps have experienced a similar drop, including The Guardian’s, and proposed that the decline might be because the apps just enable too much sharing, even for Facebook: “they felt more like the kind of cold, descriptive, invisible and yet mandatory services we’re used to seeing from Google rather than genuinely new and useful tools for spreading information.” SF Weekly’s Dan Mitchell agreed, calling the apps “spam, purchase Zoloft for sale, basically.”

But there seemed to be something amiss with such a simple explanation. Jeff Sonderman of Poynter noticed that there was a huge change in most apps’ statistics around April 10, and TechCrunch’s Josh Constine hypothesized that the drop was a result of Facebook’s transition to “Trending Articles,” which made social reader articles much less prominent in users’ news feeds. That theory was confirmed by editors at the Post and the Guardian, Fast shipping Zoloft, as the Lab’s Justin Ellis found.

From this explanation came a different lesson for news orgs — as GigaOM’s Mathew Ingram argued, with a social reader, “Facebook owns you, in the sense that it controls access to your content. Zoloft For Sale, It controls who sees it and when, and it controls how it is displayed — or even whether it is displayed.” Sonderman made a similar point and also touched on the user annoyance issue.

Facebook, for its part, australia, uk, us, usa, countered that engagement on many of its social apps is up, and Poynter’s Andrew Beaujon pointed out that even though there was a valid logistical explanation for the user decline, many observers still insisted on sticking to user annoyance as the root cause.

This week, on ‘as AOL turns’: AOL’s been providing us with a steady supply of drama over the past couple of years, Zoloft use, and this week came the latest bits of maneuvering: A month after she was reported to have gained more power in an executive reshuffling, Arianna Huffington acknowledged at a conference that her role at AOL has been shrunk back to just The Huffington Post, as The Wall Street Journal reported. (When AOL bought HuffPo, she had been put in charge of all of the site’s editorial content, though some of its brands have since been folded into HuffPo.)

As Huffington told it, she asked for the role reduction as an attempt to focus more specifically on HuffPo and gain more independence for her site, herbal Zoloft. She also said she’d been approached by private-equity firms trying to buy HuffPo from AOL, though she said nothing had come of it. Huffington insisted her relationship with AOL CEO Tim Armstrong was fine, but others were skeptical, Zoloft For Sale. New York magazine’s Joe Coscarelli said it’s tough not to see this as “a crack in the facade of a relationship many believed to be doomed from the start.”

GigaOM’s Mathew Ingram was similarly dubious, and he also explored some possibilities for a HuffPo sale, concluding that Huffington will either take her site private again or end up taking over the whole operation at AOL. Where can i cheapest Zoloft online, Forbes’ Jeff Bercovici wondered why AOL doesn’t just sell HuffPo anyway, but reasoned, as Ingram did, that AOL has invested all of its content resources into HuffPo, leaving the company with very little in the way of media if it were to sell. AOL, he argued, overpaid for HuffPo on the premise that it could replicate the site’s model across its other properties, real brand Zoloft online, which hasn’t panned out.

AOL also announced its most recent quarterly earnings, which were higher than expected, though one of its key ad metrics was down, and, Is Zoloft safe, as All Things D’s Peter Kafka reported, its traffic continues to slide. Meanwhile, PandoDaily (made up largely of ex-TechCrunchers) reported that AOL is shopping TechCrunch and Engadget for $70 million to $100 million. Armstrong denied Zoloft For Sale,  that, and TechCrunch said the rumors of a sale actually originated from AOL’s aborted plans to spin the two blogs into their own company.

A deepening scandal and rising profits for News Corp.: It was a quieter week for News Corp. after the whirlwind of the last few weeks, but there were a few smaller developments, taking Zoloft. The company’s British newspaper division missed another deadline for its latest government accounting report, and its second-biggest investor, Saudi Prince Alwaleed bin Talal, voiced his frustration with the phone hacking scandal’s influence on the company. Here in the States, Online buying Zoloft hcl, 70,000 people have signed a petition to ask Congress to investigate the scandal for potential breaches of U.S. law, Zoloft For Sale.

Amid all this, News Corp.’s profits keep growing. Its net income grew 47 percent, and its profits, announced this week, Zoloft no prescription, beat analysts’ estimates. The company’s costs from the scandal keep soaring, too, hitting $167 million since last summer. The New York Times’ David Carr said News Corp.’s continued profits and its board’s ongoing support of Rupert Murdoch might make him still seem invincible, Buy Zoloft from canada, but he’s still on an irreversible fall. Zoloft For Sale, He pinned much of blame for News Corp.’s tone-deafness on the board, saying that “the primary reason Mr. Murdoch has not been held to account is that the board of News Corporation has no independence, little influence and no stomach for confronting its chairman.” Former Times editor Bill Keller, meanwhile, said Murdoch’s greater shame will be Fox News’ pretensions at honest journalism.

—

Reading roundup: A few smaller stories running a little bit more under the radar this week:

— Jason Pontin of Technology Review wrote a piece on how publishers have grown disillusioned with apps after expecting them to do so much to restore their old business models, concluding regarding his own publication’s app experience: “I hated every moment of our experiment with apps, where can i order Zoloft without prescription, because it tried to impose something closed, old, and printlike on something open, new, and digital.” GigaOM’s Mathew Ingram echoed Pontin’s discontent with apps, and Dave Winer and Doc Searls touted the superiority of rivers of news over apps.

— The New York Times’ Binyamin Applebaum documented the frenetic daily routine of Business Insider blogger Joe Weisenthal, and Reuters’ Felix Salmon responded that Weisenthal’s style isn’t something indicative of bloggers in general, but unique to his distinctive personality.

— Finally, Belgian developer Stijn Debrouwere wrote a fantastic post on the astounding number of ways that journalism is being chipped away at by services and sites that aren’t journalistic themselves, but that are being consumed by people instead of news. Give it a read — it’s probably the best piece about the state of journalism yet this year.

Similar posts: Zoloft No Rx. Bactrim For Sale. Glucophage Price. Tramadol coupon. Glucophage for sale. Cephalexin reviews.
Trackbacks from: Zoloft For Sale. Zoloft For Sale. Zoloft For Sale. Where can i find Zoloft online. Where can i order Zoloft without prescription. Order Zoloft online c.o.d.

[This review was originally posted at the Nieman Journalism Lab Buy Armour No Prescription, on April 13, 2012.]

Facebook scoops up Instagram: There were two billion-dollar deals in the tech world this week, and by far the bigger of the two was Facebook’s purchase of the photo-sharing app Instagram. Mathew Ingram of GigaOM has a good, quick roundup of initial reaction to the deal, but I’ll try to sort through each of the angles to the story, including what this means for Facebook, Instagram, and the tech world in general. Buy Armour online cod, The first big question was why Facebook bought Instagram, especially for so much money. The most common answer, voiced most persuasively by GigaOM’s Om Malik, was that Facebook felt threatened by Instagram’s ascendance in mobile photo sharing, one area in which Facebook has struggled. Business Insider’s Nicholas Carlson explained why Instagram does mobile photos so much better than Facebook, and Fortune’s Dan Primack suggested that Facebook panicked at all the money Instagram has raised recently, Armour maximum dosage.

The New York Times also characterized the deal as a big move by Facebook into mobile media, but there were other key aspects at work, too: Ingram said Instagram’s value lay in its network, and Wired’s Tim Carmody said what matters to Facebook is Instagram’s personal data, Buy Armour No Prescription. Rackspace’s Robert Scoble outlined some of the specifics of that data, and All Things Digital’s Lauren Goode focused on Instagram’s location data. New York’s Paul Ford said Facebook is attempting to buy Instagram’s sincerity: “Remember what the iPod was to Apple. That’s how Instagram might look to Facebook: an artfully designed product that does one thing perfectly.”

So what does this mean for Instagram. TechCrunch detailed the company’s rise, and the big concern was, Ordering Armour online, as CNN’s John Sutter put it, whether Facebook would “ruin” Instagram. Mashable’s Christina Warren urged Facebook Buy Armour No Prescription,  to keep Instagram mobile-only and keep it separate from Facebook logins, and Jolie O’Dell of VentureBeat pointed out some of the good things Facebook’s developers could do for Instagram. TechCrunch noted that Facebook’s statement that it would keep Instagram as a separate product is a big departure from Facebook’s unified approach.

That concern over Facebook ruining Instagram indicates a certain revulsion for Facebook among Instagram users, something Om Malik took note of. Forbes’ John McQuaid said the sentiments reveal our uneasiness with the utility-like role tech giants like Facebook are playing in our new social world, and The Next Web’s Courtney Boyd Myers reminded Instagram users that the fact that they loved it so much was a big part of the reason it got bought in the first place.

The next question was for the tech industry as a whole: Does Instagram’s massive purchase price signal another tech market bubble, online Armour without a prescription. The Atlantic’s Rebecca Greenfield said it’s just time to accept the existence of a social media bubble, and the Guardian’s Charles Arthur said we may not be at the peak of inflated valuations, though also at the Guardian, Dan Gillmor said we could be near the end of the bubble, Buy Armour No Prescription. But Wired’s Andy Baio crunched the numbers and said Instagram wasn’t overvalued, and if anything, the tech market is rewarding efficiency. Forbes’ Robert Hof, meanwhile, looked at whether we’ll see more social media purchases soon, Armour schedule, coming up with some reasons for a slowdown.

Finally, Poynter’s Jeff Sonderman looked at some of the ways journalists have used Instagram, and Reuters’ Jack Shafer put the deal in the context of the larger cultural shift from voice to text to images. “So, Instagram is here,” he said. “What I want to know is: Where is it going to take us?”

 

Buy Armour No Prescription, Apple, publishers, Amazon, and ebooks’ future: The ebook industry absorbed a blow this week when the U.S. Department of Justice sued Apple and five of the largest book publishers for antitrust violations involving price-fixing for ebooks, cheap Armour. (Sixteen states also filed a lawsuit of their own.) Three of the publishers — Hachette, Simon & Schuster, and HarperCollins — immediately settled with the DOJ, and Wired’s Tim Carmody explained the terms of the settlement, which will undermine the model that the publishers created with Apple, though not kill it outright. Armour duration, Apple, Penguin, and Macmillan have decided not to settle, and the latter’s CEO issued a defiant letter in response to the suit.

PaidContent’s Laura Hazard Owen wrote a fantastic explanation of what the case is about, but in short, the issue centers on what’s called agency pricing, in which the publishers set book prices, Armour blogs, rather than the retailers, and the books must be at the same price across retailers. In 2010, Apple negotiated an agency pricing model with the big book publishers for the rollout of its iPad’s iBookstore, and the DOJ objected to that as price-fixing, Buy Armour No Prescription.

The Verge’s Nilay Patel dug through more of the details from the lawsuit of the alleged price-fixing process, particularly its response to Amazon’s perceived ebook dominance. At the same time, however, Buy generic Armour, as Peter Kafka of All Things Digital noted, Apple was allegedly considering a deal to divide and share rulership over online content with Amazon. A few people said the DOJ wasn’t likely to win the suit: Law prof Richard Epstein said the agency pricing arrangement has more social and consumer benefits than a classic collusion case, and CNET concluded that Apple should be able to win its case, too. Adam Thierer of the Technology Liberation Front put the strategy in the context of copyright challenges, coming out against the suit in the process. Buy Armour No Prescription, Also this week, we found out that several of the big publishers have refused to sign their annual contracts with Amazon, as Salon’s Alexander Zaitchik reported and Laura Hazard Owen explained. The Seattle Times has been running a critical series on Amazon, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release, which, as the Los Angeles Times pointed out, includes some real concern about Amazon behaving anti-competitively by selling ebooks for too little.

Publishers have argued that that’s why agency pricing is necessary: It’s the best chance to keep Amazon from undercutting publishers and laying waste to the book industry. Web thinker Tim O’Reilly said the government should be watching Amazon more closely than the five companies it just sued, but Nate Hoffelder of The Digital Reader defended Amazon, Online buying Armour, arguing that it’s helping enable an entirely new publishing model in its stead.

Christopher Mims of Technology Review said it doesn’t matter if Amazon becomes a monopoly. And GigaOM’s Mathew Ingram also said Amazon’s practices have been good for consumers and good for innovation, unlike those of the publishers: “They seem to have spent most of their time dragging their feet and throwing up roadblocks to any kind of innovation … Their defense of the agency-pricing model feels like yet another attempt to stave off the forces of disruption, Buy Armour No Prescription. Why not try to adapt instead?”

Microsoft’s big patent purchase: The other billion-dollar deal drew less attention, but could be an important one beneath the tech industry’s surface: Microsoft paid just more than $1 billion for more than 800 AOL patents, outbidding Amazon, eBay, Google, and Facebook for the intellectual property trove, comprar en línea Armour, comprar Armour baratos. The patents involve advertising, search, mobile media, and e-commerce, and includes the patents underpinning Netscape, as All Things D reported. Effects of Armour, CNET’s Jay Greene and Stephen Shankland described a few of the more interesting patents potentially involved in the deal and pointed out that Microsoft’s work may have been closer to AOL’s than any other potential buyer. Dealbook’s Michael de la Merced characterized the deal as part of a “gold rush” on patents in the tech world. Buy Armour No Prescription, On AOL’s end, The New Yorker’s Nicholas Thompson worried that the money from the deal will go to appease shareholders rather than create new products, and ZDNet’s Andrew Nusca was also skeptical of the sale’s value for AOL, wondering why the company couldn’t take advantage of the patents itself. “To me, AOL’s decision to sell this part of the portfolio shows a lack of confidence in its ability to execute in these areas,” he wrote.

Remembering Mike Wallace: One of the most legendary figures in the news industry died last weekend — Mike Wallace, longtime journalist for CBS and 60 Minutes in particular. The New York Times has a definitive obituary, Armour online cod, and CBS has some more personal remembrances. The Times also collected responses to Wallace’s death, in which he was remembered as a tough-minded reporter: The New Yorker’s Ken Auletta described him as a pioneer of investigative journalism on television. Likewise, New York’s Matt Zoller Seitz gave a thoughtful appreciation of Wallace’s “informed showmanship”: “He was our stand-in, asking the questions that we might have asked if we were there and had his skill and nerve.”

Others had more personal stories: The legendary investigative reporter Seymour Hersh, longtime Philly television columnist Gail Shister, j-prof Dan Kennedy, and The Wrap’s Sharon Waxman, Buy Armour No Prescription. As Kennedy wrote: “I really do think there was a golden age of television news, and Wallace was right in the middle of it.”

Reading roundup: Plenty of other interesting pieces to keep up with this week:

— A few more takes on last week’s purchase of the Philadelphia Inquirer and Daily News by a group of local investors: The New York Times’ David Carr mused on the return of the newspaper baron, the American Journalism Review’s John Morton examined the recent spree of newspaper purchases in a downtime for the industry, Purchase Armour online no prescription, and Penn prof Victor Pickard argued for more systemic solutions to save papers like Philly’s.

— A couple of interesting pieces from the academic view of journalism: NYU’s Jay Rosen and MIT’s Ethan Zuckerman talked about trends in journalism at an MIT forum (summarized well by Matt Stempeck), and CUNY’s C.W. Anderson talked a bit about his research on data journalism to Tyler Dukes of Reporters’ Lab.

— The debate over the value of online commenting continues: Animal’s Joel Johnson proposed that comments are worth far less than publishers think, because they don’t draw many readers and don’t make money, but GigaOM’s Mathew Ingram countered that comments are an important check on online authority and that not allowing them tells readers to “go away.”

— News analyst Alan Mutter made the age-old argument that newspapers are failing in their digital efforts in a brief, potent piece decrying newspapers’ poor digital products and weak competitive response, and urging them to pool their efforts.

— Finally, Digital First Media’s Steve Buttry wrote a gracious but no-nonsense letter to newsroom curmudgeons defending digital journalism practices, then wrote about what he learned from its fallout, then addressed the role of news organizations themselves in enabling curmudgeonhood. The posts and comments are a good glimpse into the current state of newsroom culture and change.

Similar posts: Retin A Mg. Buy Diflucan No Prescription. Synthroid For Sale. Discount Glucophage. Get Synthroid. Tramadol pics.
Trackbacks from: Buy Armour No Prescription. Buy Armour No Prescription. Buy Armour No Prescription. Low dose Armour. Order Armour from United States pharmacy. Armour gel, ointment, cream, pill, spray, continuous-release, extended-release.

Order Lipitor, [This review was originally posted on Sept. 23, 2011, at the Nieman Journalism Lab.]

Facebook ramps its sharing up even further: We had been hearing all week about a big announcement Facebook would be making this Thursday at its annual conference — about how it would mark the social network's rebirth and leave the competition in the dust. So here's what we got (in a handy roundup from Gizmodo): A Twitter-like mini-feed called Ticker (meant to make the News Feed look more like "your own personal newspaper"), apps on Facebook's Open Graph, sharing music and games through integration with services like the music player Spotify, No prescription Lipitor online, and Timeline, essentially a one-page Facebook life story.

It's pretty clear what Facebook's goal is with all of this: Put charitably, as Wired's Mike Isaac did, it's "allowing for the Facebook page to be a sort of one-stop shop, scooping up all of your activities and displaying them in one grand, blue and white frame." Put more skeptically, as the New Yorker's Nicholas Thompson did, is Lipitor addictive, Facebook wants to eat up a large chunk of the Internet, which has some real consequences: "The more our online lives take place on Facebook, the more we depend on the choices of the people who run the company—what they think about privacy, how they think we should be able to organize our friends, what they tell advertisers (and governments) about what we do and what we buy."

Tom Foremski of Silicon Valley Watcher made the point a different way, arguing that Facebook is trying to combat the natural slowdown in how much we're willing to share online by making it more frictionless and ubiquitous. Lipitor alternatives, Reactions were similar in displaying two sides of the same coin: The ability to pull together a lot of old social information into a single Timeline was either "something a lot of users wanted without much of a voice asking for it" (ZDNet's Rachel King) or a fix to "a problem absolutely no one was clamoring about" (Gawker's Adrian Chen). We'll get more of a sense of which side is more accurate over the next several months, Order Lipitor.

—

Facebook meets news apps: Another one of the changes announced by Facebook on Thursday was the addition of several new Facebook-based news apps, the first of which was the Wall Street Journal's WSJ Social, unveiled on Tuesday. (Others, like the Washington Post's and Yahoo's, were announced on Thursday.) As the Lab's Megan Garber explained, the app allows each user to edit their own stream of Journal material, is Lipitor safe, and to follow and rank others based on their editing.

As Forbes' Jeff Bercovici pointed out, the app seems to serve both the Journal's and Facebook's interests quite nicely: It keeps people's news consumption and interaction within Facebook, but allows the Journal to sell its own ads within the app and keep the money. (Facebook gets everything for the ads outside the app.)

There were questions about the app — Adweek's Dylan Byers wondered how fond people would be of an app that curates content from only one source, and GigaOM's Mathew Ingram questioned how well the socially oriented app would work with a hard paywall, Herbal Lipitor, and more generally, whether it's wise for news organizations to leave so much of their user interaction inside Facebook.

—

AOL's struggles and the future of online content: The AOL/TechCrunch saga Order Lipitor, seems to be (mercifully) winding down this week — the last real drama took place late last week, when one TechCrunch writer, Paul Carr, quit with a scorched-earth post directed at new editor Erick Schonfeld, and Schonfeld disputed his claims. But the bad news continues to roll in for AOL: The sales director for its hyperlocal news project, Patch, left — the second top AOL ad exec to bolt in the past month. Business Insider reported that AOL may lose $30 million on Patch this year. And AOL's prospects as a content-based company in general don't look rosy, as paidContent's Robert Andrews pointed out, online Lipitor without a prescription, looking at the declining revenues for AOL Europe once it dropped Internet access from its business model.

AOL execs remain positive in the face of all the bad news: Arianna Huffington said her Huffington Post's merger with AOL has been a boon for both HuffPo and Patch, thanks to the new synergies between the two operations. On the advertising side, AOL CEO Tim Armstrong said he hopes to catch Microsoft and Google in online display ads, a tall task, Order Lipitor.

Outside the company, of course, skeptics still abound. Where can i find Lipitor online, Bloomberg Businessweek's Peter Burrows declared AOL and its fellow web portal Yahoo dead companies walking, saying they "have tried to live by Old Media rules while masquerading as New Media powerhouses." And at Adweek, Michael Wolff pointed to AOL and Yahoo's struggles as evidence that online content can't sustain a business model. The only content that can still do that, he said, is TV or video: "What still works, what advertisers and audiences still seek, is superexpensive content."

—

Netflix's big split: It wasn't related to journalism per se, Lipitor pictures, but the big story at the intersection of media and tech this week was the announcement of Netflix's split into two businesses — one for streaming video online, and a new one, Qwikster, to continue its DVD-by-mail service. The change was welcomed by approximately no one: Not users or investors, as the New York Times reported, Buy generic Lipitor, not analysts like Business Insider's Henry Blodget (who said it's bad for customers) and paidContent's Robert Andrews (who said it's bad for business), and not the Oatmeal's Matthew Inman, who summed up the head-scratching nature of the move as well as anyone. Order Lipitor, Of course, Netflix had to have a reason for doing this, and there were several popular guesses, rounded up well by Tim Carmody of Wired. As Carmody explained, there are two main theories: 1) Separating DVDs and streaming makes it easier and cheaper for Netflix to negotiate rights with Hollywood (best articulated by venture capitalist Bill Gurley), and 2) Netflix wants to let its DVD business die in peace, without taking streaming down with it (argued in two posts by tech writer Dan Frommer). Along the lines of the latter theory, rx free Lipitor, GigaOM's Mathew Ingram likened Netflix's situation to the news business and wondered who would be the first newspaper company to spin off its print product from its digital side.

—

The News Corp. scandal and a press freedom threat: It's been a couple of months since News Corp.'s phone-hacking scandal was making big headlines, but the problems stemming from it continue to spread week by week. Deadline New York's David Lieberman looked at some of the financial signs indicating that the fallout may not be isolated to News Corp.'s British newspaper division, Order Lipitor. This week, a couple of aspects of the scandal heated up as another wound down: News Corp. Lipitor over the counter, is expected to settle its highest-profile hacking case (with the family of a murdered 12-year-old girl) for $4.7 million, while the U.S. Justice Department reportedly began asking the company for information in its investigation into bribery charges, and new allegations of hacking into a former government official's voicemail emerged.

Meanwhile, apart from News Corp., the story briefly sparked a press freedom fight when Scotland Yard invoked an espionage law to threaten the Guardian to give up its anonymous sources on one of the hacking cases. Order Lipitor, Journalists across Britain, including some from competitors like the Daily Mail, rose up to defend the Guardian, and within a few days, police dropped their threat. The backlash was strong enough that members of Parliament will question one of Scotland Yard's top officials over the plan, about Lipitor.

—

Reading roundup: Tons of other little things going on this week. Here's a quick tour:

— Some interesting media fallout from WikiLeaks' recent diplomatic cable release: Al Jazeera's news director resigned after the cables showed that he had modified the network's Iraq war coverage based on pressure from the U.S. This, of course, raised questions about Al Jazeera's independence and credibility. Elsewhere, British journalism thinker Charlie Beckett talked about what WikiLeaks can tell us about where news is headed, Order Lipitor. Buy Lipitor without a prescription, — Though its changes were trumped by Facebook, Google+ unveiled several new features and announced that it's open to everyone. J-prof Dan Reimold declared the new social network dead, but Wired's Tim Carmody explained how Google+'s changes are meant to change that.

— The Washington Post's Monica Hesse wrote a thought-provoking piece on journalists' tendency to obsess with things happening on social networks, leading to insights that ... aren't that insightful. If you're interested in using social media in a way that's actually worthwhile, fast shipping Lipitor, Poynter's Mallary Jean Tenore has a good guide to ways journalists can use Twitter before, during, and after reporting a story.

— At Silicon Valley Watcher, Matthew Buckland did a fascinating Q&A with Wired editor Chris Anderson — the first half on the decline of the open web, and the second on what journalism is now. Lipitor steet value, — This week's most interesting piece of media-related research comes from NYU's Tim Libert, who looked at thousands of comments about the online hacking group LulzSec, finding that the discourse indicated that the group is "in the position of villain rather than the champion of the people’s rights, as they would presumably like to be seen."

— Finally, the AP's Jonathan Stray wrote a stirring piece on what it would look like if we merged journalism with "maker culture," concluding, "This is a theory of civic participation based on empowering the people who like to get their hands dirty tinkering with the future. Maybe that’s every bit as important as informing voters or getting politicians fired.".

Similar posts: Zoloft For Sale. Purchase Cephalexin. Order Glucophage. Low dose Zoloft. Lipitor duration. Zoloft pictures.
Trackbacks from: Order Lipitor. Order Lipitor. Order Lipitor. Generic Lipitor. Taking Lipitor. Where to buy Lipitor.

[This review was originally posted at the Nieman Journalism Lab Cipro Dosage, on Sept. 16, 2011.]

Paid and free, side by side: The Boston Globe became the latest news organization to institute an online paywall this week, but it did so in an unprecedented way that should be interesting to watch: The newspaper created a separate paid site, BostonGlobe.com, Order Cipro from United States pharmacy, to run alongside its existing free site, Boston.com. PaidContent has the pertinent details: A single price ($3.99 a week), and Boston.com gets most of the breaking news and sports, while BostonGlobe.com gets most of the newspaper content. The Lab's Justin Ellis, meanwhile, buy no prescription Cipro online, has a look at the lab that designed it all.

As the Globe told Poynter's Jeff Sonderman, the two sites were designed with two different types of readers in mind: One who has a deep appreciation for in-depth journalism and likes to read stories start-to-finish, and another who reads news casually and briefly and may be more concerned about entertainment or basic information than journalism per se.

The first thing that caught many people's attention was new site's design — simple, clean, and understated, Cipro Dosage. Tech blogger John Gruber gave it a thumbs-up, Buy Cipro without prescription, and news design guru Mario Garcia called it "probably the most significant new website design in a long time." The Lab's Joshua Benton identified the biggest reasons it looks so clean: Far fewer links and ads.

Benton (in the most comprehensive post on the new site) also emphasized a less noticeable but equally important aspect of BostonGlobe.com's design: It adjusts to fit just about any browser size, which eliminates the need for mobile apps, making life easier for programmers and, as j-prof Dan Kennedy noted at the Lab, a way around the cut of app fees required by Apple and others. If the Globe's people "have figured out a way not to share their hard-earned revenues with gatekeepers such as Apple and Amazon, then they will have truly performed a service for the news business — and for journalism, Cipro trusted pharmacy reviews," Kennedy said.

Of course, the Globe could launch the most brilliantly conceived news site on the web, but it won't be a success unless enough people pay for it. Poynter's Sonderman (like Kennedy) was skeptical of their ability to do that, Ordering Cipro online, though as the Atlantic's Rebecca Rosen pointed out, the Globe's plan may be aimed as much at retaining print subscribers as making money off the web. The Washington Post's Erik Wemple wondered Cipro Dosage, if readers will find enough at BostonGlobe.com that's not at Boston.com to make the site worth their money.

—

The TechCrunch conflict and changing ethical standards: Last week's flap between AOL and TechCrunch over the tech site's ethical conflicts came to an official resolution on Monday, when TechCrunch founder Michael Arrington parted ways with AOL, the site's owner. But its full effects are going to be rippling for quite a while: Gawker's Ryan Tate called the fiasco a black eye for everyone involved, but especially AOL, Cipro samples, which had approved Arrington's investments in some of the companies he covers just a few months ago. Fellow media mogul Barry Diller also ripped AOL's handling of the situation.

At the Guardian, Dan Gillmor said that while he doesn't trust TechCrunch much personally, it's the audience's job to sort out their trust with the help of transparency, Cipro recreational, rather than traditional journalism's strictures. Others placed more of the blame on TechCrunch: Former Newsweek tech editor Dan Lyons said TechCrunch's people should have expected this type of scenario when they sold to a big corporation, and media analyst Frederic Filloux said TechCrunch is a perfect example of the blogosphere's vulnerability to unchecked conflicts of interest.

There was more fuel for those kinds of ethical concerns this week, as the winning company at TechCrunch's annual Disrupt competition was one that Arrington invests in, Cipro Dosage. But Arrington had an ethical accusation of his own to make at the conference, pointing out that the New York Times invests in a tech venture capital fund which has put $3.5 million into GigaOM, a TechCrunch competitor. Poynter's Steve Myers detailed the Times' run-ins between the companies it invests in and the ones it covers (and its spotty disclosure about those connections), concluding that even if the conflict is less direct than in blogging, comprar en línea Cipro, comprar Cipro baratos, it's still worth examining more closely.

As it plunged further into its battle with TechCrunch late last week, AOL was also reported to be talking with Yahoo, which recently fired its CEO, about a merger between the two Internet giants. Cheap Cipro no rx, All Things Digital's Kara Swisher said there's no way the deal would actually happen, and Wired's Tim Carmody called it a "spectacularly crazy idea" and GigaOM's Mathew Ingram agreed, while Business Insider reminded us that they said a year ago that AOL and Yahoo should merge. Cipro Dosage, Meanwhile, the New York Times' David Carr homed in on the core problem that both companies are facing: The fact that people want information online from niche sites, not giant general-news portals. "As news surges on the Web, giant ocean liners like AOL and Yahoo are being outmaneuvered by the speedboats zipping around them, relatively small sites that have passionate audiences and sharply focused information," he wrote.

—

Facebook opens to subscribers: It hasn't gotten nearly as much attention as some of its other moves, but Facebook took another step in Twitter's direction this week by introducing the Subscribe Button, which allows users to see other people's (and groups') status updates without friending or becoming a fan of them.

As GeekWire's Monica Guzman and many others noted, buy cheap Cipro no rx, Facebook's "subscribe" looks a heck of a lot like Twitter's "follow." When asked about similar Google+ features at the TechCrunch Disrupt conference, a Facebook exec said it wasn't a response to Google+.

Guzman said Facebook is putting down deeper roots by going beyond the limits of reciprocal friendship, and GigaOM's Mathew Ingrampinpointed the reason why this could end up being a massive change for Facebook: It's beginning to move Facebook from a symmetrical network to an asymmetrical one, which could fundamentally transform its dynamics. Still, Cipro brand name, Ingram said Twitter is much better oriented toward being an information network than Facebook is, even with a "Subscribe" button.

The change could have particularly interesting implications for journalists, as Poynter's Jeff Sonderman explained in his brief outline of the feature. As he noted, it may eliminate the need for separate Facebook profiles and pages for journalists, and while Lost Remote's Cory Bergman said that should be a welcome change for journalists who were trying to manage both, he noted that shows and organizations may want to stick with pages, Cipro Dosage.

—

News Corp.'s scandal widens: An update on the ongoing scandal enveloping News Corp.: A group of U.S. banks and investment funds that own shares in News Corp. expanded a lawsuit to include allegations of stealing, hacking, purchase Cipro for sale, and anti-competitive behavior by two of the company's U.S. subsidiaries — an advertiser and a satellite TV hardware manufacturer. As the Washington Post's Erik Wemple noted, these are old cases, but they're getting fresh attention, Cipro dosage, and that's how scandals gain momentum. Cipro Dosage, James Murdoch, the son of News Corp.'s Rupert Murdoch, was also recalled to testify again before members of Britain's Parliament later this fall, facing new questions about the breadth of News Corp.'s phone hacking scandal. The Wall Street Journal examined the scandal's impact on the elder Murdoch's succession plan for the conglomerate, especially as it involves James. The company's executives also announced this week that they've found tens of thousands of documents that could shed more light on the phone hacking cases.

—

Reading roundup: Here's what else went on this week:

— The biggest news story this week, of course, is actually 10 years old: Here's a look at how newspapers marked the anniversary of 9/11, real brand Cipro online, how news orgs used digital technology to tell the story, and a reflection on how 9/11 changed the media landscape.

— Twitter introduced a new web analytics tool to measure Twitter's impact on websites. Here's an analysis from Mathew Ingram of GigaOM, Cipro Dosage.

— At an academic conference last weekend, Illinois j-prof Robert McChesney repeated his call for public funding for journalism. Purchase Cipro online no prescription, Here are a couple of good summaries of his talk from fellow j-profs Axel Bruns and Alfred Hermida.

— Finally, here's a relatively short but insightful two-part interview between two digital media luminaries, Henry Jenkins and Dan Gillmor, about media literacy, citizen journalism and Gillmor's latest book. Should make for a quick, thought-provoking weekend read.

Similar posts: Lipitor Price. Flagyl For Sale. Bactrim Mg. Kjøpe Lipitor på nett, köpa Lipitor online. Zoloft pics. Canada, mexico, india.
Trackbacks from: Cipro Dosage. Cipro Dosage. Cipro Dosage. Cheap Cipro no rx. Cipro dose. Buy Cipro online cod.

[This review was originally posted at the Nieman Journalism Lab Order Glucophage, on Sept. 9, 2011.]

TechCrunch, ethics, and new notions of journalism: The prominent tech news site TechCrunch tends to find itself in the middle of some controversy or another fairly regularly. Usually they're relatively inconsequential inside baseball, but this week's blowup is by far its biggest, and it spurred some enlightening discussion outside of the tech-news bubble, canada, mexico, india.

Here's the quick summary of what happened (the Guardian has a fuller version): Michael Arrington, TechCrunch's founder and editor, launched a venture capital fund to invest in tech companies — the same companies TechCrunch covers. AOL, which bought the site last year, responded by taking him off of TechCrunch and moving him to the business side in an arrangement that no one completely understood. Arrington fired back with an ultimatum: Give TechCrunch total editorial freedom, or sell it back to him, Order Glucophage. Effects of Glucophage, AOL has reportedly countered by booting Arrington entirely. Whatever happens, TechCrunch's MG Siegler said the site won't likely be the same.

There were conflicting views on the impact of Arrington's reported ouster, of course — Reuters' Felix Salmon said AOL is losing its top journalist, while Fortune's Chadwick Matlin said the fall of TechCrunch would be good for the tech industry. But the central issue here was the ethics of Arrington's arrangement — investing in the same companies his site covers, something he's been doing openly for years, real brand Glucophage online.

The critique was articulated most strongly by the New York Times' David Carr Order Glucophage, , who documented several instances of TechCrunch writing favorable pieces on companies in which Arrington had invested, calling the arrangement "almost comically over the line." All Things Digital's Kara Swisher delivered an angrier version — "A giant, greedy, Silicon Valley pig pile" — and many others were also critical, including the Atlantic's Alexis Madrigal, Rem Rieder of the American Journalism Review, and VentureBeat's Dylan Tweney.

TechCrunch had its defenders, too, including Gawker's Ryan Tate, who argued for the hypocrisy of AOL's Arianna Huffington's sudden concern about ethics. The most thorough defenses, though, Glucophage coupon, came from TechCrunch's writers themselves: First, Paul Carr asserted that the new company would have nothing to do with TechCrunch. Then, both Carr and MG Siegler responded to David Carr's column by arguing that their site doesn't have the editorial workflow that its critics assume, and by criticizing the Times for its own ethical conflicts. "Ultimately there is only one thing that matters: information. People don’t care how they get it, just that they get it. If they don’t think they can trust it from one source, they’ll find another way to get it," Siegler wrote, Order Glucophage.

Some observers, buy cheap Glucophage no rx, like New York mag's Chris Rovzar, called that defense naive. In a terrific post here at the Lab, j-prof C.W. Anderson looked a bit deeper into the ways TechCrunch's philosophy challenges traditional journalism's norms, particularly the site's commitment to transparency as its primary ethical safeguard and its idea of the supremacy of information. About Glucophage, There was also the question of whether Arrington should have to abide by journalistic standards in the first place. Arrington asserted Order Glucophage, that he's not a journalist, and tech pioneer Dave Winer argued that "journalism itself is becoming obsolete." GigaOM's Mathew Ingram countered that journalism is still alive, just evolving and expanding, and j-prof Jeff Jarvis said journalism defies definition, and that's just fine.

—

A bigger challenge for Digital First: John Paton has grabbed a lot of attention with his rejuvenation of the formerly bankrupt newspaper chain the Journal Register Co., and this week, his project expanded to include a much larger (also formerly bankrupt) company, MediaNews Group, which owns papers such as the Denver Post, St. Paul Pioneer Press, Glucophage gel, ointment, cream, pill, spray, continuous-release, extended-release, and Detroit News. Though the two companies will remain formally separate, Paton will manage both companies under the auspices of the newly created Digital First Media.

Paton briefly reiterated his digitally centered philosophy in a blog post on the move, and GigaOM's Mathew Ingram called him the "patron saint" of the digitally focused, open approach to newspapers, Buy Glucophage no prescription, as opposed to the more print-protectionist, paywall-oriented one. Reuters' Felix Salmon said Paton's model of leveraging local sales staff and trusted editorial content for digital revenue makes much more sense than the hyperlocal-en-masse Patch model, Order Glucophage.

There's another important aspect to this deal, though: the Journal Register Co. was bought this summer by Alden Global Capital, a hedge fund that also owns a significant stake in MediaNews and several other newspaper companies. The Lab's Joshua Benton provided some background on that situation, and Ken Doctor predicted that the move "may mark just the beginning of a local newspaper roll-up, Glucophage cost, resulting in the United States’ first truly national local news(paper) company," noting that Paton's Digital First initiative is also accompanied by major cost-cutting. At the Knight Digital Media Center, Amy Gahran expressed concern that Paton's plans could run aground on an entrenched traditional culture at MediaNews and the impatience of hedge-fund investors. Order Glucophage, MediaNews also has newly installed paywalls at 23 papers, and Paton told paidContent he isn't sure yet what will happen to them. But one change has already been made: MediaNews' contract with copyright litigant Righthaven has been ended.

—

WikiLeaks under fire: We talked last week about the inadvertent release of the rest of WikiLeaks' archive of 251, Glucophage pharmacy, 000 diplomatic cables and the fallout that ensued. As it happened, WikiLeaks decided late last week to go ahead and publish all of the unredacted cables themselves, given that they had already been leaked online.

The decision led to more criticism — not just from the traditional media, but from others on the web: the Personal Democracy Forum's Micah Sifry, author of a book on WikiLeaks, chastised the organization for the dump, online buy Glucophage without a prescription, saying it's thrown away the moral high ground. Consultant Tom Watson said WikiLeaks' move has damaged their efforts at transparency and an empowered society, and James Ball, a former WikiLeaks volunteer, made the same point more powerfully by painting a picture of an internal culture at odds with the group's stated ideals of accountability and openness. "WikiLeaks has done the cause of internet freedom – and of whistleblowers – more harm than US government crackdowns ever could," he said, Order Glucophage.

Tech blogger Dave Winer, however, After Glucophage, was more troubled by the traditional media's eagerness to blame and ostracize Assange for the incident. It's not about one person, he said, it's about the technology that makes WikiLeaks possible: "They have a method that they have religious feelings about, ones that some of us don't share, and that method is broken by the Wikileaks model." Mediaite's Frances Martel, meanwhile, wondered why no one seemed to care about the documents themselves, herbal Glucophage.

—

Yahoo fires its CEO: After a tumultuous two-and-a-half-year tenure, Yahoo CEO Carol Bartz was fired this week. The next step for the troubled Internet giant could be to engineer a sale, as CNNMoney's Paul La Monica urged it to do. Order Glucophage, Plenty of names were tossed around as potential buyers, most recently Yahoo co-founder Jerry Yang.

The Wall Street Journal detailed what's gone wrong at Yahoo, and Om Malik of GigaOM was one of many who pinned many of the company's failings on its board. Glucophage reviews, Malik called for Yahoo to rid itself of everything that connects it to the Internet's past, and Business Insider's Pascal-Emmanuel Gobry advised Yahoo to "own the fact that it's a media and content company," encouraging a strategy that looks quite similar to AOL's. PaidContent's David Kaplan noted that Yahoo has a lot of ground to make up in display advertising, and Mark Walsh of MediaPost wondered if we'll see more of an emphasis on mobile media from Yahoo now.

—

Reading roundup: Just a couple more items for this week:

— One piece of news to note: Google has killed FastFlip, the magazine-like news presentation tool it launched in 2009.

— As we continue to move closer to bona fide campaign season, Glucophage maximum dosage, the Columbia Journalism Review's Greg Marx offered a smart response to Jay Rosen's critique of political journalism last week, defending the usefulness of certain kinds of the much-maligned "horse-race journalism."

— On the practical side, Florida j-prof Mindy McAdams put together a handy list of 10 tips to compelling visual storytelling. It's a great resource for professionals, j-profs, and students.

Similar posts: Lipitor Cost. Cephalexin No Rx. Buy Retin A No Prescription. Armour results. Synthroid price, coupon. Armour price, coupon.
Trackbacks from: Order Glucophage. Order Glucophage. Order Glucophage. Order Glucophage online overnight delivery no prescription. Buy Glucophage online no prescription. Glucophage price, coupon.